rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Nutex Health Inc.

NUTX · Nasdaq

IndustrialsBusiness ServicesIn trend

NUTX stood above a rising 150-day average in 34 of the last 52 weekly readings, including each of the last 8 weeks. It is 22.9% above that average now. Business Services: 32% of its 115 stocks in an uptrend (−6 points in four weeks); Industrials: 26% (−5 points in four weeks).

Statistics

Rotation
In trend
Weeks in an uptrend
8 in a row
Industry in uptrend
32% -6 in 4 wk
Insider buys, 12 months
$194K
Insider sales, 12 months
$87K
Officials’ trades on record
0
Institutions holding
147 (+26)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 34 of 52 weeks.

20 Apr – 19 Oct
18%31%44%Apr 26Jun 26Jul 26Sep 26Oct 26

Business Services: A minority of its stocks are in an uptrend and the share has been slipping. Industrials: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$80K$0$96KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months5
Sale orders, 12 months1
Buyers · sellers5 · 1
WhoDidSharesTraded
Scott J. SaundersDirectorsold203at $214.2518 Sep 2026filed 18 Sep 2026
Frank E. JaumotDirectorbought150at $93.5620 Mar 2026filed 23 Mar 2026
Warren HosseinionPresidentbought252at $94.0719 Mar 2026filed 23 Mar 2026
Kelvin SpearsDirectorbought10at $94.4617 Mar 2026filed 18 Mar 2026
Pamela W. MontgomeryChief Legal Officer-Healthcarebought79at $88.8713 Mar 2026filed 16 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders147+26 on the quarter
New · exited40 · 13
Reported value$492.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Pertento Partners LLPadded · filed 13 Aug 2026451,310$77.1M+77,340+20.7%
BlackRock, Inc.added · filed 7 Aug 2026407,349$69.6M+27,994+7.4%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026237,414$40.6M+33,964+16.7%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026215,919$36.9M-3,212−1.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026132,049$22.6M+9,936+8.1%
STATE STREET CORPadded · filed 7 Aug 2026130,836$22.4M+7,659+6.2%
D. E. Shaw & Co., Inc.new · filed 14 Aug 202697,454$16.7M+97,454
UBS Group AGadded · filed 13 Aug 202677,912$13.3M+8,342+12.0%
WINMILL & CO. INCunchanged · filed 13 Aug 202665,350$11.2M00.0%
Focus Partners Wealthnew · filed 12 Aug 202660,881$10.4M+60,881
30 Jun 2024 – 30 Jun 2026
775142Jun 24Dec 24Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Scott J. Saunders Company insiderDirector · last 18 Sep 20260 · 1
Cheryl Yvonne Grenas Company insiderDirector · last 31 Jul 20261 · 0
Frank E. Jaumot Company insiderDirector · last 31 Jul 20261 · 0
Michael Lee Reed Company insiderDirector · last 31 Jul 20261 · 0
Kelvin Spears Company insiderDirector · last 4 Jun 20261 · 0
Thomas T. Vo Company insiderChief Executive Officer · last 28 May 202614 · 0
Warren Hosseinion Company insiderPresident · last 19 Mar 20262 · 7
Pamela W. Montgomery Company insiderChief Legal Officer-Healthcare · last 13 Mar 20262 · 0
Jon Christian Bates Company insiderChief Financial Officer · last 11 Mar 20264 · 0
Wesley Shane Bamburg Company insiderChief Operating Officer · last 11 Mar 20260 · 0
Elisa Luqman V Company insiderChief Legal Officer - SEC · last 10 Mar 20260 · 0
Michael L. Chang Company insiderChief Medical Officer · last 10 Mar 20260 · 0

Same industry

CBZ CbizLeading+34%
DHX DHI GroupLeading+26%
TISI TeamLeading+19%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202550.8%
Operating profit marginFY 2025 · to 31 Dec 202531.5%
Free cash flow marginFY 2025 · to 31 Dec 202528.1%
Return on capital employedFY 2025 · to 31 Dec 202536.2%
Cash conversionFY 2025 · to 31 Dec 2025351%
Debt to equityFY 2025 · to 31 Dec 20250.13×
Share count trendFY 2025 · to 2 Mar 2026-1.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$185.6M
Free cash flowFY 2025 · to 31 Dec 2025$245.6M

Analyst forecasts

No analyst forecasts yet.